CUAMC
ANIP icon

China Universal Asset Management Company’s ANI Pharmaceuticals ANIP Stock Holding History

China Universal Asset Management Company’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$299K Sell
3,618
-360
-9% -$28.9K 0.02% 324
2026
Q1 		$306K Buy
3,978
+318
+9% +$24.8K 0.02% 313
2025
Q4 		$289K Sell
3,660
-142
-4% -$12.3K 0.02% 312
2025
Q3 		$348K Sell
3,802
-547
-13% -$44.6K 0.03% 281
2025
Q2 		$284K Sell
4,349
-16
-0.4% -$1.04K 0.03% 283
2025
Q1 		$292K Sell
4,365
-92
-2% -$5.5K 0.03% 286
2024
Q4 		$246K Buy
4,457
+412
+10% +$23.7K 0.02% 313
2024
Q3 		$241K Buy
4,045
+1,582
+64% +$96.5K 0.03% 282
2024
Q2 		$157K Sell
2,463
-1,570
-39% -$102K 0.02% 268
2024
Q1 		$279K Buy
4,033
+1,666
+70% +$101K 0.04% 250
2023
Q4 		$131K Buy
2,367
+1,854
+361% +$102K 0.03% 251
2023
Q3 		$29.8K Buy
513
+248
+94% +$14.3K 0.01% 268
2023
Q2 		$14.3K Buy
265
+29
+12% +$1.28K ﹤0.01% 295
2023
Q1 		$9.37K Buy
236
+58
+33% +$2.45K ﹤0.01% 299
2022
Q4 		$7.16K Buy
+178
New +$6.69K ﹤0.01% 259

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Global Alpha Capital Management
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's ANIP Position: Q2 2026 in Review

China Universal Asset Management Company reduced its ANI Pharmaceuticals (ANIP) stake by 9% in Q2 2026, selling an estimated $28.9K and leaving 3,618 shares worth $299K. The position accounts for 0.02% of the portfolio, ranked #324.

China Universal Asset Management Company first reported a position in ANIP in Q4 2022 and has held it in 15 quarters since. The position peaked at $348K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • China Universal Asset Management Company held 3,618 shares of ANI Pharmaceuticals worth $299K as of Q2 2026.
  • China Universal Asset Management Company sold 360 ANI Pharmaceuticals shares in Q2 2026, an estimated $28.9K.
  • ANI Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #324 holding.
  • China Universal Asset Management Company first reported a position in ANI Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's ANI Pharmaceuticals position peaked at $348K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.